DIANA Biotechnologies develops RT-PCR diagnostic kits and monoclonal antibodies, utilizing proprietary DIANA technology to enhance clinical diagnostics and drug discovery processes. The company addresses the need for reliable and efficient testing solutions in respiratory virus detection and supports the development of targeted therapies in the biotech sector.
Funding
$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods for pathogen detection and protein analysis often lack the sensitivity and efficiency required for rapid diagnostics and effective drug discovery. Existing diagnostic tools may struggle with accuracy and speed, while drug discovery processes can be slow and resource-intensive.
Solution
DIANA Biotechnologies develops and provides innovative solutions across the biotech sector, including clinical diagnostics, academic research, and drug discovery. The company leverages its proprietary DIANA technology to create highly sensitive and efficient RT-PCR diagnostic kits, custom oligonucleotide synthesis, and monoclonal antibodies. DIANA Biotechnologies offers a comprehensive portfolio of products and services, including RT-PCR panels for respiratory virus detection, PCR mixes, enzymes, and custom monoclonal antibody development. Additionally, they provide drug discovery services, such as kinase and CDK panels, to accelerate breakthroughs in pharmaceutical R&D.
Target Audience
DIANA Biotechnologies serves diagnostic and academic labs, hospitals, research institutions, and pharmaceutical companies seeking advanced tools for diagnostics, life science research, and drug discovery.
Features
- Proprietary DIANA technology for enhanced sensitivity and efficiency in pathogen and protein detection
- RT-PCR panels for rapid and accurate diagnostics of respiratory viruses, including SARS-CoV-2
- Custom oligonucleotide synthesis with a streamlined online calculator
- Development of custom monoclonal antibodies using DIANA technology
- Drug discovery services, including DIANA Kinase and CDK panels for inhibitor profiling
- DBscript Reverse Transcriptase for superfast protocols
- In-house production with complete quality control and assurance